Search All News
A pilot feasibility study to assess new therapy addresses a critical gap in treatment options for a high-risk patient population with unique emotional needs.
Despite growing evidence of efficacy and safety, however, access to this form of therapy remains largely inaccessible to those who need it the most.
The award recognizes residents who go above and beyond their duties to foster a culture of collaboration and excellence.
A new study suggests that mothers who experience poor sleep during pregnancy, particularly during the second trimester, are more likely to have children with neurodevelopmental issues.
- October 27, 2021
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”
- September 21, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
- September 15, 2021
Dr. Sidney Hankerson is one of 10 scholars named as 2021’s Emerging Leaders in Health and Medicine by the National Academy of Medicine (NAM).
- September 13, 2021
Ravi N. Shah, MD has been named Chief Innovation Officer for Columbia Psychiatry.
Source:U.S. NewsJuly 19, 2021
Dr. Joshua Berman said electrical stimulation (ECT) seems to trigger the release of "neurotrophic" factors, which can help brain cells grow.
Source:NBC NewsJuly 16, 2021
“Our study provides further evidence that marijuana use is not effective in reducing nonmedical opioid use,” said study author Dr. Mark Olfson.
Source:TIMEJuly 13, 2021
“The biggest limiting factor in getting to remission from depression postpartum is access to care, period—and it is worse for people who don’t have financial resources,” says Dr. Catherine Monk.